# CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

> clinical trial · VERIFIED · 2026-06-15

Status: TERMINATED · Sponsor: Regeneron Pharmaceuticals · Condition: Melanoma

- Company: Regeneron Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04695977

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.